Skip to content

Clinical trials

Completed Phase 3 Pulmonary Embolism trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Phase: Phase 3 Status: Completed Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20033
20041
20051
20062
20079
20081
20091
20105
20111
20122
20131
20141
20152
20161
20174
20191
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed42

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Bristol-Myers Squibb4
Crux Biomedical3
Daiichi Sankyo3
GlaxoSmithKline3
McMaster University3
Sanofi3
Academic and Community Cancer Research United2
Boston Scientific Corporation2
University of Padova2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism42
Venous Thrombosis25
Venous Thromboembolism19
Thrombosis4
Hemorrhage3
Neoplasms3
Thromboembolism3
Intracranial Thrombosis2
Neoplasm Metastasis2
Brain Neoplasms1

Trials

Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.